Manuel H Aguiar-Oliveira Selected Research

Genu Valgum

8/2017	MECHANISMS IN ENDOCRINOLOGY: The multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation.
11/2013	Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel H Aguiar-Oliveira Research Topics

Disease

32	Pituitary Dwarfism 04/2022 - 07/2002
10	Insulin Resistance 01/2019 - 06/2007
8	Atherosclerosis 11/2020 - 12/2007
3	Facies 01/2021 - 08/2017
3	Infections 01/2021 - 10/2016
3	Hypopituitarism (Sheehan's Syndrome) 11/2020 - 07/2009
2	Abdominal Obesity 01/2021 - 08/2017
2	Leishmaniasis 01/2019 - 10/2016
2	Genu Valgum 08/2017 - 11/2013
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2021
1	COVID-19 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2020
1	Neoplasms (Cancer) 08/2018
1	Ependymoma 08/2018
1	CHARGE Syndrome 01/2018
1	Sensorineural Hearing Loss 08/2017
1	Dizziness (Lightheadedness) 08/2017
1	Communicable Diseases (Infectious Diseases) 10/2016
1	Immune System Diseases (Immune Disorders) 10/2016
1	Tetanus 10/2016
1	Hepatitis B 10/2016
1	Non-alcoholic Fatty Liver Disease 09/2014
1	Glucose Intolerance 06/2013
1	Atherosclerotic Plaque (Atheroma) 06/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2011
1	Periodontal Diseases (Periodontal Disease) 06/2011
1	Hypercholesterolemia 02/2010
1	Death (Near-Death Experience) 05/2009
1	Myocardial Infarction 05/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2009
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 02/2009

Drug/Important Bio-Agent (IBA)

23	somatotropin releasing hormone receptorIBA 04/2022 - 04/2003
11	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 06/2007
10	Hormones (Hormone)IBA 01/2022 - 07/2002
5	Growth Hormone (Somatotropin)IBA 10/2016 - 04/2007
3	LDL CholesterolIBA 11/2020 - 07/2008
3	C-Reactive ProteinIBA 08/2017 - 07/2008
3	Glucose (Dextrose)FDA LinkGeneric 06/2013 - 03/2012
3	Insulin (Novolin)FDA Link 09/2012 - 06/2007
2	Retinaldehyde (Retinal)IBA 08/2017 - 10/2016
2	AdipokinesIBA 11/2011 - 02/2010
1	AntibodiesIBA 01/2021
1	fibroblast growth factor 21IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Pituitary HormonesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2020
1	CalciumIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	AcidsIBA 08/2017
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2017
1	Insulin-Like Growth Factor Binding ProteinsIBA 08/2017
1	Immunoglobulin G (IgG)IBA 10/2016
1	CreatinineIBA 01/2016
1	Transaminases (Aminotransferases)IBA 09/2014
1	Cortisone FDA Link 09/2014
1	EnzymesIBA 09/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2014
1	Oxidoreductases (Dehydrogenase)IBA 09/2014
1	SteroidsIBA 08/2013
1	ProlactinIBA 08/2013
1	OsteocalcinIBA 09/2012
1	glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA 09/2012
1	AlbuminsIBA 02/2010
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 02/2009
1	CholesterolIBA 07/2008
1	LipidsIBA 07/2002

Therapy/Procedure

1	Radiotherapy 01/2021
1	Operative Surgical Procedures 08/2018
1	Therapeutics 08/2018
1	Myocardial Revascularization 05/2009